Amagi Media Labs IPO Subscribed 6% on Day 1; Analysts Advise 'Subscribe' Despite Tepid GMP

Business
M
Moneycontrol•13-01-2026, 17:34
Amagi Media Labs IPO Subscribed 6% on Day 1; Analysts Advise 'Subscribe' Despite Tepid GMP
- •Amagi Media Labs IPO opened on January 13, subscribed 6% on Day 1, receiving bids for 1.747 million shares against 27.3 million offered.
- •Retail Individual Investors (RII) showed most interest, subscribing 28% of their reserved portion; Non Institutional Investors (NII) subscribed 4%.
- •The IPO aims to raise Rs 17.89 billion through a fresh issue of Rs 8.16 billion and an offer for sale of Rs 9.73 billion.
- •Price band is Rs 343-361 per share; minimum bid of 41 shares (Rs 14,801). IPO closes January 16, listing on January 21.
- •Analysts like Anand Rathi and Prasenjit Paul recommend 'Subscribe' for long-term, citing Amagi's SaaS model, global exposure, and growth potential in digital advertising.
Why It Matters: Amagi Media Labs IPO sees low initial subscription but analysts recommend long-term 'Subscribe' due to its SaaS model and growth.
✦
More like this
Loading more articles...





